Duane Morris partner Frederick R. Ball will be serving as a moderator on a session titled “The Present Part 2: Generic Industry Challenges and Current Issues” at the Food and Drug Law Institute’s conference. The conference, Celebrating the 30th Anniversary of the Hatch-Waxman Amendments: The Past, Present and Future of Generic Drugs, will take place on September 18, 2014 in Washington, D.C. Mr. Ball’s session will begin at 1:45 p.m.
About the Conference
This year marks the 30th Anniversary of the Hatch-Waxman Amendments, which were enacted to promote generics while keeping financial incentives for research and development for brand manufacturers. Join us for this timely a one-day conference that explores why the Act was passed, where we are right now in terms of FDA and industry developments, and what’s on the horizon in terms of ongoing brand-generic issues Speakers from Capitol Hill, FDA, the private bar and industry will provide practical insights on the impact of the Hatch-Waxman Amendments, controversial issues currently facing generic drug manufacturers and their counsel. Don’t miss out on this historic event.
For more information or to register, please visit the FDLI website.